Fulvenat 250mg Injection is an estrogen blocker used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by blocking & degrading estrogen receptors helps to slow down the cancer cells. Fulvenat 250 mg contains an active FDA approved ingredient Fulvestrant. Fulvenat 250mg injection is an intramuscular injection given usually into the buttock muscles that can only be administered by a trained professional at hospitals and clinics. It can prescribed alone or with other cancer medicines, depending on the cancer stage and your doctor’s treatment plan.
Fulvenat 250 contains Fulvestrant, an estrogen receptor degrader help postmenopausal women treat hormone receptor-positive advanced / metastatic breast cancer. It works by binding to estrogen receptors on cancer cells, that help estrogen to prevent from stimulating those cells. Fulvestrant is approved by U.S. FDA committee in the year 2002 under the brand Faslodex for advanced breast cancer. Fulvestrant is not given during the pregnancy & breast feeding.
Fulvenat 250mg Injection is an anticancer medicine used in the treatment of breast cancer in women who have gone through menopause. It works to slow down the growth of cancer cells.
Generally, in postmenopausal women, there is a significant imbalance of hormones, especially estrogen. In response to this hormonal imbalance, there is the development of breast cancer cells that spread locally or to other parts of the body. This type of cancer is known as estrogen-receptor (ER) positive breast cancer. Fulvenat 250 is primarily used to treat this type of cancer as it blocks the estrogen receptors responsible for the growth and survival of malignant cells.
As a part of anti-cancer treatment, hormonal therapies such as aromatase inhibitors or anti-estrogen drugs are used. Despite this, there might be a development of estrogen-receptor (ER) positive breast cancer. In such cases, Fulvenat 250 is used, as the cancer can develop resistance to hormone therapies. As this medication destroys the estrogen receptors, the cancer cells are unable to grow and proliferate any further.
In HER2- negative breast cancers, the malignant cells express both estrogen receptors, as well as alternative cell signalling receptors. Hence, for HR-positive, HER2-negative breast cancers, a combination anticancer therapy is typically used. This combination therapy includes Fulvenat 250 and other drugs such as Palbociclib or Abemaciclib, which would slow down the cell growth.
In women with breast cancer who have undergone hormonal therapy, sometimes the cancer may relapse, which makes any further hormonal therapy inefficient. In such a condition, Fulvenat 250 is used as it can inhibit the estrogen receptor activity in malignant cells, which is essential for cancer cell survival.
->.Missed dose instructions:
->.Overdose instructions:
->.Recommended dose:
->.Maximum dose:
->.Missed dose instructions:
->.Overdose instructions:
For this condition, Fulvenat 250 can be combined with any of the following medications:
->.Recommended dose:
->.Maximum dose:
->.Missed dose instructions:
->.Overdose instructions:
->.Recommended dose:
->.Missed dose instructions:
->.Overdose instructions:
You can buy Fulvenat 250mg Injection from Lifesaving-meds.com at low price online with free shipping & free sample medicines. Lifesaving-meds.com provide Fulvenat 250mg Injection at very less wholesale price for sale from India with low price guarantee, big discounts, free delivery, credit card / debit card, Zellepay, paypal, crypto / Bitcoin payment option & more in the United states of America (USA) – New York, California, Texas, Florida, Ohio, Oregon, Georgia, Denver, Illinois, Oregon, Pennsylvania, Washington, Wyoming & more; United Kingdom (UK) – London, Birmingham, Wales, Manchester & more; Europe (EU) – Moscow (Russia), Paris (France), Spain & more; and Australia (AU) – Sydney, Melbourne, Brisbane & more. So, buy Fulvenat 250mg Injection near you when you are prescribed with this medication or search as Fulvenat 250mg Injection for sale near me on google, bing, yahoo, duckducko, AOL & anywhere.
Fulvenat 250mg Injection consists of Fulvestrant is a hormonal drug, mainly used for the treatment of breast cancers with different phenotypes.
In breast cancer cells, the estrogen receptor (ER) is essential to facilitate cell proliferation and tumor growth. This type of cancer is known as estrogen receptor-positive (ER-positive) breast cancer.
Fulvenat 250 mimics the structure of the estrogen hormone and competitively binds to the ERs. Although this drug mimics the structure of estrogen, it does not activate the cell survival signalling pathways in malignant cells. Instead, it blocks and causes structural changes to these ERs. For these mechanisms, Fulvestrant is known as a selective estrogen receptor degrader (SERD).
Once these ERs are broken down, the functional machinery in the malignant cells also breaks down. As a result, despite the presence of estrogen molecules, the tumor cells can no longer grow and proliferate efficiently. In this way, Fulvenat 250 can effectively control the growth of hormone-dependent breast cancer, especially in advanced or metastatic stages.
->.Hormonal or reproductive effects
->.Blood and bleeding-related effects
->.Liver-related effects
->.Cardiovascular or respiratory effects
->.Allergic reactions (rare but serious)
Fulvenat 250mg Injection works by inhibiting the estrogen receptors on cancer cells, which prevents tumor growth.
A Fulvenat 250mg injection is generally given intramuscularly.
The combination of Fulvenat 250mg Injection with other drugs can only be decided by a specialist.
Hair loss after taking Fulvenat 250mg Injection is rare. However, some patients may experience hair thinning.
Fulvenat 250mg Injection therapy lasts until an adequate cancer reduction is determined by the medical practitioner.
